Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Transplant Recipient”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT02630563
What this trial is testing

Safety, Tolerability and Pharmacokinetics of Oral CellCept (Mycophenolate Mofetil) in Pediatric Liver Transplant Recipients on Concomitant Treatment With Cyclosporine and Corticosteroids

Who this might be right for
Pediatric Liver Transplantation
Hoffmann-La Roche 9
Early research (Phase 1)Study completedNCT00320606
What this trial is testing

Withdrawal of Immunosuppression in Pediatric Liver Transplant Recipients

Who this might be right for
Liver TransplantLiver Transplantation
National Institute of Allergy and Infectious Diseases (NIAID) 20
Not applicableNot Yet RecruitingNCT07176806
What this trial is testing

The Use of Urinary Dickkopf 3 (u DKK3) as a New Biomarker Which Can Identify Patients at High Risk of Renal Allograft Dysfunction, Earlier That the Current Established Tests.

Who this might be right for
Renal Transplant Failure
Guy's and St Thomas' NHS Foundation Trust 258
Post-approval studies (Phase 4)Study completedNCT02624349
What this trial is testing

Immunogenicity and Safety of Human Papilloma Virus Vaccine in Solid Organ Transplant Recipients

Who this might be right for
Late Complication From Kidney TransplantComplication of Transplanted LiverHuman Papillomavirus-Related Carcinoma
The Hospital for Sick Children 37
Not applicableActive Not RecruitingNCT06564649
What this trial is testing

PROACT Pilot Trial

Who this might be right for
Kidney Transplant Rejection
University of British Columbia 60
Not applicableStudy completedNCT05697458
What this trial is testing

Vascular Calcifications in Kidney Transplant Recipient

Who this might be right for
Arterial CalcificationKidney FailureKidney Transplant; Complications
Clinical Hospital Center Rijeka 70
Testing effectiveness (Phase 2)Looking for participantsNCT07771855
What this trial is testing

Efficacy of an Anti-TSLP Monoclonal Antibody in the Management of Chronic Bronchial Disease Induced by Bronchiolitis Obliterans Syndrome in Allogeneic Hematopoietic Stem Cells Transplantation Recipients

Who this might be right for
Bronchiolitis Obliterans Syndrome (BOS)HSCTBronchial Disease
Hopital Foch 36
Not applicableStudy completedNCT06760143
What this trial is testing

Antibiotic Prophylaxis in Lung-Transplant Recipients

Who this might be right for
Lung-transplant RecipientsAntibiotic Prophylaxis
IRCCS Azienda Ospedaliero-Universitaria di Bologna 90
Not applicableStudy completedNCT03299504
What this trial is testing

Factors Predicting Success in Lung Transplant Recipients Who Have Undergone Intensive Post-operative Rehabilitation

Who this might be right for
Lung Transplant
Indiana University Health Methodist Hospital 105
Early research (Phase 1)Looking for participantsNCT03943238
What this trial is testing

TLI, TBI, ATG & Hematopoietic Stem Cell Transplantation and Recipient T Regs Therapy in Living Donor Kidney Transplantation

Who this might be right for
Living Donor Kidney Transplantation
Stanford University 22
Early research (Phase 1)UnknownNCT05195125
What this trial is testing

Use of Direct Peritoneal Resuscitation in High-risk Liver Transplant Recipients

Who this might be right for
End Stage Liver DIseaseObesityAcute Kidney Injury
University of Colorado, Denver 15
Not applicableUnknownNCT06344117
What this trial is testing

Assessment of Volatile Organic Compounds (VOC) for the Diagnosis of Invasive Aspergillosis (IA) in Lung Transplant Recipients

Who this might be right for
Invasive Aspergillosis
Owlstone Ltd 45
Not applicableStudy completedNCT02867293
What this trial is testing

Impact Of Timing Of Drainage Of Massive Ascites On Operative And Post-Operative Course In Living-Donor Liver Transplant Recipients. A Prospective Randomized Controlled Trial.

Who this might be right for
Massive Ascites
Mansoura University 80
Large-scale testing (Phase 3)Study completedNCT02040584
What this trial is testing

A Multicentre, Randomised, Open-label, Controlled, 12-month Follow-up Study to Assess Impact on Renal Function of an Immunosuppression Regimen Based on Tacrolimus Minimisation in Association With Everolimus in de Novo Liver Transplant Recipients.

Who this might be right for
Liver Transplant
Novartis Pharmaceuticals 217
Not applicableLooking for participantsNCT07141043
What this trial is testing

Assessment of Mineral and Bone Disorders in Kidney Transplant Recipients

Who this might be right for
HemodyalysisKidney TansplantOsteoporosis+1 more
Grigore T. Popa University of Medicine and Pharmacy 180
Testing effectiveness (Phase 2)Looking for participantsNCT06599658
What this trial is testing

COVID-19 Booster and IIV Schedule in Immunocompromised Hosts

Who this might be right for
COVID 19InfluenzaRheumatoid Arthritis (RA)+5 more
McGill University Health Centre/Research Institute of the McGill University Health Centre 660
Post-approval studies (Phase 4)UnknownNCT04224350
What this trial is testing

Study to Evaluate the Efficacy and Safety of Tacrolimus in Kidney Transplant Recipients (BLOSSOM)

Who this might be right for
Kidney Transplant
Chong Kun Dang Pharmaceutical 184
Not applicableUnknownNCT04024618
What this trial is testing

Feasibility Study Comparing Enteral vs Parenteral Nutritional Outcomes in Autologous Stem Cell Transplant Patients

Who this might be right for
Malignant Hematologic Neoplasm
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 40
Not applicableStudy completedNCT02826460
What this trial is testing

Psychosocial Risks in Liver Transplant Recipients

Who this might be right for
End Stage Liver Disease
Icahn School of Medicine at Mount Sinai 200
Testing effectiveness (Phase 2)Looking for participantsNCT07053462
What this trial is testing

CRISPR-Edited HLA Donor Kidney Transplant to Reduce Rejection Risk

Who this might be right for
End-Stage Renal DiseaseEnd Stage Renal Disease on DialysisEnd Stage Renal Disease With Renal Transplant+4 more
AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC 90
Next Page